Jingjie Xiao1, Angelina Cain2, Sarah A Purcell1, Michael J Ormsbee3, Robert J Contreras4, Jeong-Su Kim5, Robert Thornberry6, Dawn Springs2, M Cristina Gonzalez7, Carla M Prado8. 1. Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada; Department of Nutrition, Food and Exercise Sciences, College of Human Sciences, Florida State University, Tallahassee, FL, USA. 2. Tallhassee Memorial Bariatric Center, Tallahassee Memorial Hospital, Tallahassee, FL, USA. 3. Department of Nutrition, Food and Exercise Sciences, College of Human Sciences, Florida State University, Tallahassee, FL, USA; Institute of Sports Sciences and Medicine, Florida State University, Tallahassee, FL, USA; Department of Biokinetics, Exercise and Leisure Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. 4. Department of Psychology, College of Arts and Sciences, Florida State University, Tallahassee, FL, USA. 5. Department of Nutrition, Food and Exercise Sciences, College of Human Sciences, Florida State University, Tallahassee, FL, USA; Institute of Sports Sciences and Medicine, Florida State University, Tallahassee, FL, USA. 6. Tallahassee Orthopedic Clinic, Tallahassee, FL, USA. 7. Post Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, RS, Brazil; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. 8. Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada; Department of Nutrition, Food and Exercise Sciences, College of Human Sciences, Florida State University, Tallahassee, FL, USA. Electronic address: carla.prado@ualberta.ca.
Abstract
AIM: To investigate the prevalence of sarcopenic obesity (SO) and its association with health outcomes in patients seeking weight loss treatment from a bariatric center. METHODS: In this retrospective study, patients [≥18 years old, body mass index (BMI) ≥30 kg/m2] from the Tallahassee Memorial Bariatric Center and with baseline body composition assessment by bioelectrical impedance analysis were included. Fat mass index (FMI = fat mass/height2) and fat-free mass index (FFMI = fat free mass/height2) were calculated. SO was defined by a FMI/FFMI ratio greater than the 95 percentile of sex, BMI and ethnicity specific population-representative references. Medical records were reviewed for biochemical and comorbidity measures. RESULTS: One hundred and forty-four patients (∼69% females, mean age 55.6 years, mean BMI 46.6 kg/m2) were included. Patients' FMI/FFMI ratios ranged from 0.35 to 1.60 kg/m2 across body weight spectrum, with 51% having SO. Blood pressure, fasting glucose, triglycerides, HDL or LDL were not different between patients with and without SO. However, the prevalence of high cholesterol, asthma, alcoholism and hernia were higher in patients with SO. SO was the strongest univariate predictor of high cholesterol (OR = 2.08, 95% CI 1.07-4.04) and asthma (OR = 2.77, 95% CI = 1.12-6.83). CONCLUSION: SO was prevalent and associated with adverse health outcomes, beyond that captured by anthropometric measures in the present study.
AIM: To investigate the prevalence of sarcopenic obesity (SO) and its association with health outcomes in patients seeking weight loss treatment from a bariatric center. METHODS: In this retrospective study, patients [≥18 years old, body mass index (BMI) ≥30 kg/m2] from the Tallahassee Memorial Bariatric Center and with baseline body composition assessment by bioelectrical impedance analysis were included. Fat mass index (FMI = fat mass/height2) and fat-free mass index (FFMI = fat free mass/height2) were calculated. SO was defined by a FMI/FFMI ratio greater than the 95 percentile of sex, BMI and ethnicity specific population-representative references. Medical records were reviewed for biochemical and comorbidity measures. RESULTS: One hundred and forty-four patients (∼69% females, mean age 55.6 years, mean BMI 46.6 kg/m2) were included. Patients' FMI/FFMI ratios ranged from 0.35 to 1.60 kg/m2 across body weight spectrum, with 51% having SO. Blood pressure, fasting glucose, triglycerides, HDL or LDL were not different between patients with and without SO. However, the prevalence of high cholesterol, asthma, alcoholism and hernia were higher in patients with SO. SO was the strongest univariate predictor of high cholesterol (OR = 2.08, 95% CI 1.07-4.04) and asthma (OR = 2.77, 95% CI = 1.12-6.83). CONCLUSION: SO was prevalent and associated with adverse health outcomes, beyond that captured by anthropometric measures in the present study.
Authors: Josje D Schoufour; Michael Tieland; Rocco Barazzoni; Somaya Ben Allouch; Joey van der Bie; Yves Boirie; Alfonso J Cruz-Jentoft; Doris Eglseer; Eva Topinková; Bart Visser; Trudy Voortman; Amalia Tsagari; Peter J M Weijs Journal: Front Nutr Date: 2021-05-24
Authors: Erika Aparecida Silveira; Jacqueline Danésio de Souza; Ana Paula Dos Santos Rodrigues; Ricardo M Lima; Camila Kellen de Souza Cardoso; Cesar de Oliveira Journal: Nutrients Date: 2020-05-21 Impact factor: 5.717